Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases

  • Jian Zhang1,
  • Wan Xia Xiao2,
  • Yuan Feng Zhu3, 4,
  • Fatuma Said Muhali3,
  • Ling Xiao3,
  • Wen Juan Jiang3,
  • Xiao Hong Shi3,
  • Lian Hua Zhou3 and
  • Jin An Zhang3Email author
BMC Endocrine Disorders201313:26

https://doi.org/10.1186/1472-6823-13-26

Received: 22 October 2012

Accepted: 19 July 2013

Published: 29 July 2013

Abstract

Background

The abnormality of interleukin-21 (IL-21)-IL-21-receptor (IL-21R) system has been found in many autoimmune diseases including autoimmune thyroid diseases (AITDs). In this study, we investigated whether polymorphisms of the IL-21 and IL-21R are associated with Graves’ disease (GD) and Hashimoto’s thyroiditis (HT), two major forms of AITDs, among a Chinese population.

Methods

Rs907715, rs4833837, rs2221903 and rs2055979 of the IL-21 gene and rs3093301 and rs2285452 of the IL-21R gene were explored in a case–control study including 405 GD, 228 HT patients and 242 controls. These genes were genotyped by the PCR and restriction fragment length polymorphism (RFLP) analysis and the MASS spectrometry method.

Results

For IL-21 gene, we identified and confirmed a higher prevalence of A alleles of rs2221903 (P = 0.018, OR = 1.50 95% CI = 1.07-2.09) in GD patients. We also found a significant association between rs2221903 and HT (allele: P = 0.009, OR = 1.69 95% CI = 1.13-2.51; genotype: recessive P = 0.021, OR = 11.72 95% CI = 1.46-94.13). For the IL-21R gene, compared with controls, the genotype frequencies of rs3093301 and rs2285452 were significantly different in HT patients using dominant genetic model (P = 0.023, OR = 1.61 95% CI = 1.07-2.42; P = 0.031, OR = 1.71 95% CI = 1.05-2.80, respectively). Furthermore, the haplotype AA containing the major alleles of rs4833837 and rs2221903 was associated with increased susceptibility to GD with an OR of 1.50(95% CI =1.08-2.09, P = 0.016), and to HT with an OR of 1.69(95% CI =1.14-2.52, P = 0.009).

Conclusion

Our results indicated that the SNPs of the IL-21 gene is associated with the development of GD. In addition, we found that individuals with the SNPs of the common IL-21 and IL-21R may have higher risk of HT.

Keywords

Interleukin-21 (IL-21) Interleukin-21 receptor (IL-21R) Graves’ disease Hashimoto’s thyroiditis Single nucleotide polymorphism (SNP)

Background

Autoimmune thyroid diseases (AITDs), the thyroid-specific autoimmune disorders, affect about 5% of the population. The etiology of AITDs includes genetic and environmental factors resulting in immune abnormality and the development of AITDs.

In 2000, the interleukin-21(IL-21)-IL21-receptor (IL-21R) system was discovered [1]. IL-21 and IL-21R are located on human chromosome 4q26-27 and 16p11, respectively. The IL-21, preferentially produced by CD4 + T cells, has various functions, such as driving B cells to differentiate into memory cells and ultimately plasma cells, augmenting T cells’ proliferation, and promoting the activity of natural killer (NK) cells [2]. In accordance with these roles of IL-21, IL-21R is mainly expressed in B cells, T cells and NK cells, keratinocytes, and some of myeloid cells. Animal and clinical studies demonstrated the dysregulations of IL-21 and IL-21R in autoimmune diseases. For example, compared with IL-21R-competent BXSB-Yaa mice for multiple parameters of SLE, the IL-21R-deficient Yaa mice showed none of the abnormalities characteristic of systemic lupus erythematosus (SLE) [3]. IL-21R is overexpressed in the inflamed synovial membrane and in peripheral blood or synovial fluid leukocytes of rheumatoid arthritis (RA) patients [4]. And the evident increase of serum IL-21 level in primary Sjogren’s syndrome (pSS) patients has positive correlation with the levels of gamma-globulin and erythrocyte sedimentation rate [5].These suggests that IL-21 and IL-21R may play a critical role in the pathogenesis of autoimmune diseases. Recently, H.Y. Jia [6] also reported that an increase of serum IL-21 level in patients with primary GD.

In recent years, the associations between the IL-21 gene or IL-21R gene polymorphisms and autoimmune diseases have been gradually reported. In a HapMap-CEU population, a large block (480 kb) of linkage disequilibrium encompassing KIAA1109/Tenr/IL2/IL21 showed genetic associations with type 1 diabetes mellitus (T1DM) [7, 8], RA [8], juvenile idiopathic arthritis (JIA) [9], psoriasis and psoriatic arthritis(PA) [10]. Similarly, the polymorphisms of the IL2/IL21 gene region likely to confer to the susceptibility to coeliac disease in Scandinavia families [11] and a US population [12], to ulcerative colitis in a North American and an Italian cohort [13], and to multiple sclerosis in a Spanish population [14]. After the SNPs in the IL-21 gene were analyzed, the significant differences of rs907715 and rs2221903 allele and genotype frequencies were found between SLE and controls [15]. In addition to these reports, an association between microsatellite polymorphisms of the IL-21R and diabetes in Japanese patients, between rs3093301 and rs2285452 in the IL-21R gene region and SLE in the European-derived cohort were documented [16].

Therefore, it is reasonable to speculate that IL-21 and IL-21R are the candidate genes for AITDs. Plagnol [17] reported that the rs2069763 in chromosome 4q27 were associated with the GD susceptibility in a Caucasian cohort. And a recent study that indicated that rs907715 of IL-21 gene was associated with GD in a Chinese population [6].

In this study, additional variants of the IL-21 gene and two SNPs of the IL-21R gene in addition to previously reported variants were investigated in two subtypes of AITDs including GD and HT.

Methods

Patients and controls

AITDs patients and healthy controls were enrolled from the First Affiliated Hospital, Medical School of Xi’an Jiaotong University. A total of 633 independent patients with AITDs, including 405 GD and 228 HT, and 242 unrelated healthy controls were recruited. GD and HT were diagnosed based on clinical and laboratory evidence of hyperthyroidism and hypothyroidism respectively and diffuse goitre, supported by the presence of antithyroglobulin antibody (TgAb) and/or antithyroid peroxidase antibody (TPOAb) and/or exophthalmos. The controls were healthy subjects without clinical evidence or family history of any AITDs. This study was approved by the ethics committee of Jinshan hospital of Fudan University. All patients and control subjects were asked to sign an informed consent.

Genotyping

Genomic DNA was extracted from peripheral blood leukocytes using the Nucleon Bacc kit from TianGen Biotech CO. LTD (Beijing, China).

Rs907715, rs4833837, rs2221903 and rs2055979 spanning a large region which captured all common variation in the IL-21 gene and rs3093301 and rs2285452 which were only two tag-SNPs of IL-21R gene confirmed to be associated with SLE in European-derived cohort were selected from the published SNP database (http://www.ncbi.nlm.nih.gov/SNP). All of these SNPs were validated polymorphisms, and have a minor allele frequency(MAF) of more than 1%. Rs907715, rs4833837, and rs222190 are located on intron 2 of IL-21R and rs2055979 on intron 3. For IL-21R gene, rs3093301 is in intron 2 and rs2285452 in exon 10.

All of the four IL-21 SNPs and rs2285452 were typed using mass spectrometry method (Shanghai Benegene Biotechnologies CO. Ltd. Shanghai, China). Rs3093301 was typed using PCR-restriction fragment length polymorphism (PCR-RELP) method. The appropriate fragment of rs3093301 in the IL-21R gene was amplified using specific primers (forward: 5′-AATTGCTCCT CAGCAGATCC-3′, reverse: 5′-GCATCAGCCTCCCGAGTAG-3′). The PCR reaction was performed in a 25μl mixture, containing 100ng genomic DNA and 0.1 mM solution of each primer, 12.5 μl 2*Taq PCR MasterMix (TianGen Biotech CO. LTD, Beijing, China) and 9.5 μl ddH2O. PCR was carried out with initial denaturation for 5 min at 95°C, followed by 37 cycles of annealing for 30 seconds at 60°C, extension for 30 seconds at 72°C and denaturation for 30 seconds, and a final extension for 5 min at 72°C. The product (383 bp) was digested with restriction enzyme NIaIII (Fermentas Life Sciences) at 37 centigrade for 10 hours, and analyzed on a 3% agarose gel. There were three profiles of the digested fragments: 210 bp, 44 bp, and 129 bp indicating the presence of TT, two fragments of 254 bp and 129 bp indicating the presence of CC, and four fragments of 254 bp, 210 bp, 129 bp and 44 bp representing TC genotype.

Statistical analysis

In this study, we used a population-based case–control method. Statistical analysis was performed using Haploview 4.1 and SPSS 11.0. Hardy-Weinberg equilibrium (HWE) of each SNP was analyzed in controls using Goodness-of-fit test. Categorical data were analyzed by chi-square or Fisher’s exact test. For continuous data, Student’s t-test was used for the normalized data, and non-parametric test was used for non-normalized data. Furthermore, corrected P value and gene-gene interaction were analyzed using logistic regression analysis. In this study, a two-tailed P value less than 0.05 was considered to be significantly difference.

Results

Four SNPs (rs907715, rs4833837, rs2221903 and rs2055979) of the IL-21 gene and two SNPs (rs3093301 and rs2285452) of the IL-21R gene were typed in 405 GD and 228 HT patients and 242 controls. For the tested SNPs, genotyping successful rate was more than 96.9%. All of the 6 genotyped SNPs showed a MAF more than 7% and HWE analysis in the three groups showed P values of more than 0.05 (seen in Table 1). When comparing age and sex distributions between patients and controls, we found the control group matched well with the GD group, but not with HT group (seen in Table 2). The distributions of the SNPs genotypes in HT patients were analyzed using logistic regression analysis adjusted for sex and age when compared with the controls.
Table 1

Allele distributions and HWE P value of the four SNPs in IL21 gene and two SNPs in IL-21R gene

SNP ID

HWE P value

Associated allele

Count (frequency %)

GD P value (OR,95% CI)

HT P value (OR,95% CI)

Control

GD

HT

Control

GD

HT

IL-21

         

rs907715

0.634

0.968

0.085

A

208(44.6)

348(44.5)

210(46.9)

0.963

0.497

rs4833837

0.999

0.300

0.715

G

56(11.6)

86(10.6)

44(9.6)

0.606

0.340

rs2221903

0.055

0.329

0.715

A

405(84.7)

721(89.2)

412(90.4)

0.018 (1.50, 1.07-2.09)

0.009 (1.69,1.13-2.51)

rs2055979

0.507

0.999

0.484

T

186(38.9)

312(39.7)

160(36.5)

0.782

0.458

IL-21R

         

rs3093301

0.427

0.732

0.172

T

228(47.1)

387(48.0)

192(42.3)

0.752

0.138

rs2285452

0.326

0.510

0.830

A

55(11.3)

89(11.0)

36(7.9)

0.797

0.068

Table 2

Age and sex characteristics of GD and HT patients and controls

Group

Age

Sex

Kolmogorov - Smirnov P value

Z score

P value

Male/female counts

χ2

P value

control

<0.001

--

--

67/175

--

--

GD

<0.001

-0.487

0.626

114/291

0.016

0.899

HT

0.200

-2.599

0.009

27/201

18.410

1.7E-5

Association of the IL-21 gene polymorphisms with GD and HT

A genetic association between GD and HT and one of the four genotyped IL-21 SNPs was found in this study. For the SNP rs2221903 located in the intron 2 regions, the frequency of A allele was 89.2% in GD and 90.4% in HT, respectively, significantly higher than 84.7% in healthy controls (GD: P = 0.018, OR = 1.495 95% CI = 1.070-2.086; HT: P = 0.009, OR = 1.69 95% CI = 1.13-2.51). In contrast to these results, the allele frequencies of rs907715, rs4833837 and rs2055979 were similar between patients and controls (Table 1). As the distributions of rs907715, rs4833837, rs2221903 and rs2055979 genotypes in patients and controls are shown in Table 3. For rs2221903, the frequencies of the genotypes carrying risk allele (A) were higher both in GD (AA: 80.2%, GA: 18.1%) and HT (AA: 81.1%, GA:18.4%) patients than in controls (AA: 73.6%, GA: 22.2%), but statistical significance was only found when the recessive genetic model was used in HT patients (AA + GA vs. GG, P = 0.021, OR = 11.72 95% CI = 1.46-94.13), in comparison with the controls. In this study, no significant association was observed between GD or HT and rs907715, rs4833837 or rs2055979 genotypes while different genetic models were applied for analysis.
Table 3

Genotype distributions of the four SNPs of IL21 gene and two SNPs of IL-21R gene

SNP ID

Geno-type

Control

GD

HT

Count (frequency%)

Count (frequency %)

Additive P value

Dominant P value

Recessive P value

Count (frequency %)

Additive P value

Dominant P value (OR,95% CI)

Recessive P value (OR,95% CI)

IL-21

          

rs907715

GG

69(29.6)

121(30.9)

0.845

0.726

0.746

70(31.3)

0.334

0.568

0.264

GA

120(51.5)

192(49.1)

98(43.8)

AA

44(18.9)

78(19.9)

56(25.0)

rs4833837

AA

189(78.1)

325(80.4)

0.61

0.474

0.751

185(81.1)

0.67

0.667

0.401

GA

50(20.7)

72(17.8)

42(18.4)

GG

3(1.2)

7(1.7)

1(0.4)

rs2221903

AA

176(73.6)

324(80.2)

0.063

0.053

0.061

185(81.1)

0.07

0.132

0.021 (11.72,1.46-94.13)

GA

53(22.2)

73(18.1)

42(18.4)

GG

10(4.2)

7(1.7)

1(0.4)

rs2055979

GG

92(38.5)

143(36.4)

0.808

0.595

0.857

91(41.6)

0.731

0.455

0.572

GT

108(45.2)

188(47.8)

96(43.8)

TT

39(16.3)

62(15.8)

32(14.6)

IL-21R

          

rs3093301

CC

64(26.4)

111(27.5)

0.571

0.762

0.391

81(35.7)

0.079

0.023 (1.61, 1.07-2.42)

0.896

TC

128(52.9)

197(48.9)

100(44.1)

TT

50(20.7)

95(23.6)

46(20.3)

rs2285452

GG

185(77.7)

318(78.7)

0.823

0.707

0.999

193(85.0)

0.051

0.031 (1.71, 1.05-2.80)

0.435

GA

52(21.8)

83(20.5)

32(14.1)

AA

1(0.4)

3(0.7)

2(0.9)

Association of the IL-21R gene polymorphisms with GD and HT

As shown in Table 1, the rs3093301 and rs2285452 SNPs in IL-21R showed no association with GD or HT (P = 0.797-0.068).

Nominal associations were found between rs3093301 and rs2285452 and HT when the dominant genetic model (CC vs. TC + TT, P = 0.023, OR = 1.61 95% CI = 1.070-2.42); GG vs. GT + TT, P = 0.031, OR = 1.71 95%CI = 1.05-2.80, respectively) was used for analysis. Genotype analysis of rs3093301 and rs2285452 using additive and recessive genetic model did not indicate any significant difference between HT patients and controls (Table 3). For rs3093301 and rs2285452, no significant different distribution was found in GD patients and controls when different genetic models was used (showed by Table 3).

Haplotype analysis in GD and HT

As shown in Table 4, rs4833837 and rs2221903 (r-square = 0.901) were identified as an LD block using the Haploview 4.1. The total frequency of haplotypes listed in Table 5 was more than 99.0% in every group. AA containing major alleles of these two SNPs was associated with increased susceptibility to GD with an OR of 1.50 (95% CI =1.08-2.09, P = 0.016), and to HT with an OR of 1.69 (95% CI =1.14-2.52, P = 0.009) (Table 5).
Table 4

The linkage disequilibrium analysis of the SNPs in IL-21 and IL-21R gene

r-square

   

IL-21

rs4833837

rs2221903

rs2055979

rs907715

0.099

0.090

0.493

rs4833837

--

0.901

0.067

rs2221903

--

--

0.059

IL-21R

rs2285452

  

rs3093301

0.369(0.018)

  
Table 5

The frequencies of the haplotypes of IL-21 gene in patients and controls

Reference SNP

Frequency %

GD

HT

rs4833837

rs2221903

Control

GD

HT

p

OR (95% CI)

p

OR (95% CI)

A

A

84.7

89.3

90.4

0.016

1.500 (1.08-2.09)

0.009

1.694 (1.14-2.52)

G

G

11.6

10.7

9.6

0.640

0.92 (0.64-1.31)

0.340

0.816 (0.54-1.24)

A

G

3.7

0.0

0.0

4.0E-8

--

4.0E-4

--

Discussion

IL-21 is a member of the common-gamma chain family of cytokines with immunoregulatory activity. IL-21R has been shown to form a heterodimeric receptor complex with the common gamma-chain. IL-21 binding with this receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1 and STAT3, therefore affects the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells. The dysregulation of IL-21 and IL-21R plays a role in multiple immune-mediated diseases, including SLE [3], psoriasis [5], RA [4] and other chronic inflammatory diseases [18]. Like other autoimmune diseases, GD and HT are chronic diseases initiated by the loss of immunological tolerance to self-antigens. Previous studies indicate that some immune-related genes may participate in the development of AITDs.

In this study, we found a significant association between GD or HT and rs2221903 located in the IL-21 gene region, and the frequencies of the haplotypes in the IL-21 gene that consists of rs4833837 and rs2221903 in GD and HT patients were significantly different from controls. For rs3093301 and rs2285452 polymorphisms of the IL-21R gene, there were significantly different distributions of these genotypes between HT patients and the controls.

In different from Jia’s study [6], we did not find the rs907715 SNP linkage with GD. In Jia’s report, the AA genotype frequency was lower in GD patients (19.4%) than in controls (30%). The gene frequency in patients of our study was similar to that of Jia’s study, but different in the two control groups. In our study the frequency of AA genotype in the control group was 18.9%, which is similar to the frequency in the HapMap-CHB population. This may be the geographical or selection variation that results in this difference. It should be noted that the lack of association in our study does not completely exclude the possibility of IL-21R as a candidate gene for GD because of the following three reasons: 1) The average MAF of the six SNPs is 0.271, which gives our study genetic power of about 0.8 for GD and 0.7 for HT group with an OR of homozygote 2.0, and of heterozygote 1.5, therefore studies with a larger sample size are necessary to confirm whether patients with these SNPs have more risk for development of GD. 2) As many other immunologic disorders, AITDs is believed to derive from a multiple network of various susceptible loci, which exert synergic or additive effects, but each locus may play a small role [19]. 3) 13 tag-SNPs in the HapMap-CHB population and 17 in the HapMap-CEU population covered a 49.8 kb on 16p11, where IL-21R gene located. And we just explored the association between the two tag-SNPs of them and AITDs in Chinese cohort.

In genetics, a recessive gene is an allele that causes a phenotype (visible or detectable characteristic) that is only seen in a homozygous genotype (an organism that has two copies of the same allele) and never in a heterozygous genotype. While dominance is a relationship between alleles of a gene, in which one allele masks the expression (phenotype) of another allele at the same locus. Our study didn’t find any synergistic effect of the risk genotype. And we were unable to conclude whether these two genes were either recessive or dominant over the other gene.

IL-21 is located on chromosome 4q26-27, which is close to IL-2, a region that has been linked to AITDs susceptibility [17]. Jia’s et al. found rs907715 of IL-21 gene being associated with GD in a Chinese population while Plagnol found only rs2069763 and did not find association of rs2069762 and rs6822844 of IL-2 with GD, maybe there is ethnicity or regional effect contributing to these results differences. Therefore, we can not exclude that the SNPs of the IL-21 and IL-21R genes are only an indicator of a candidate gene contributing to AITDs. Further studies such as screening the rest common variations in IL21R gene, identifying the causal SNP for this association, and exploring gene-environment interaction in GD and HT cohort studies are required to clarify the effect of IL-21 and IL-21R on AITDs susceptibility. Replication of these associations between IL-21 and IL-21R gene and AITDs is also required in larger independent databases of different cohorts.

Conclusion

In conclusion, our study confirmed the synergic effect of the IL-21 SNPs in the development of GD. In addition, to the best of our knowledge, we are the first to report the association of the IL-21 and IL-21R SNPs with an increased risk of HT.

Declarations

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (30871184, 81070627).

Authors’ Affiliations

(1)
Department of Clinical Laboratory, Jinshan Hospital of Fudan University
(2)
Internal Medicine Department, Xi’an Aviation Group Hospital
(3)
Endocrinology Department, Jinshan Hospital, Fudan University
(4)
Endocrinology Department, Weinan Central Hospital

References

  1. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ: Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA. 2000, 97: 1439-1444.Google Scholar
  2. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J, Schrader S, Burkhead S, Heipel M, Brandt C, Kuijper JL, Kramer J, Conklin D, Presnell SR, Berry J, Shiota F, Bort S, Hambly K, Mudri S, Clegg C, Moore M, Grant FJ, Lofton-Day C, Gilbert T, Rayond F, Ching A: Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000, 408: 57-63. 10.1038/35040504.View ArticlePubMedGoogle Scholar
  3. Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse HC, Leonard WJ, Roopenian DC: A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci USA. 2009, 106: 1518-1523. 10.1073/pnas.0807309106.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Li J, Shen W, Kong K, Liu Z: Interleukin −21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol. 2006, 64: 515-522. 10.1111/j.1365-3083.2006.01795.x.View ArticlePubMedGoogle Scholar
  5. Yuan SL, Jiang L, Zhang XL, Li SF, Duan HM, Wang XF: Serum IL-21 level in patients with primary Sjogren’s syndrome and clinical significance of IL-21. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007, 23: 124-126.PubMedGoogle Scholar
  6. Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ: Association between interleukin 21 and Graves’ disease. Genet Mol Res. 2011, 10: 3338-3346. 10.4238/2011.October.31.6.View ArticlePubMedGoogle Scholar
  7. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447: 661-678. 10.1038/nature05911.View ArticleGoogle Scholar
  8. Zhernakova A, Alizadeh BZ, Bevova M, Van Leeuwen MA, Coenen MJ, Franke B, Franke L, Posthumus MD, Van Heel DA, Van der Steege G, Radstake TR, Barrera P, Roep BO, Koeleman BP, Wijmenga C: Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet. 2007, 81: 1284-1288. 10.1086/522037.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, Packham J, Worthington J, Thomson W: Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun. 2010, 11: 194-198. 10.1038/gene.2009.105.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J, Wise C, Miner A, Malloy MJ, Pullinger CR, Kane JP, Saccone S, Worthington J, Bruce I, Kwok PY, Menter A, Krueger J, Barton A, Saccone NL, Bowcock AM: A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008, 4: e1000041-10.1371/journal.pgen.1000041.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Adamovic S, Amundsen SS, Lie BA, Gudjónsdóttir AH, Ascher H, Ek J, Van Heel DA, Nilsson S, Sollid LM, Torinsson Naluai A: Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun. 2008, 9: 364-367. 10.1038/gene.2008.27.View ArticlePubMedGoogle Scholar
  12. Garner CP, Murray JA, Ding YC, Tien Z, Van Heel DA, Neuhausen SL: Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet. 2009, 18: 4219-4225. 10.1093/hmg/ddp364.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Festen EA, Goyette P, Scott R, Annese V, Zhernakova A, Lian J, Lefèbvre C, Brant SR, Cho JH, Silverberg MS, Taylor KD, De Jong DJ, Stokkers PC, Mcgovern D, Palmieri O, Achkar JP, Xavier RJ, Daly MJ, Duerr RH, Wijmenga C, Weersma RK, Rioux JD: Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut. 2009, 5: 799-804.View ArticleGoogle Scholar
  14. Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, Arnal C, Lucas M, Izquierdo G, Delgado C, Alcina A, Matesanz F: Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population. Tissue Antigens. 2009, 74: 244-247. 10.1111/j.1399-0039.2009.01298.x.View ArticlePubMedGoogle Scholar
  15. Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, Wakeland EK, Li QZ, Wandstrat AE, Karp DR, James JA, Merrill JT, Lipsky P, Harley JB: Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis. 2008, 67: 458-461.View ArticlePubMedGoogle Scholar
  16. Webb R, Merrill JT, Kelly JA, Sestak A, Kaufman KM, Langefeld CD, Ziegler J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, Alarcón-Riquelme ME, James JA, Gilkeson GS, Jacob CO, Moser KL, Gaffney PM, Vyse TJ, Nath SK, Lipsky P, Harley JB, Sawalha AH: A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 2009, 60: 2402-2407. 10.1002/art.24658.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, Stevens H, Jackson L, Simmonds MJ, Bingley PJ, Gough SC, Todd JA, Type 1 Diabetes Genetics Consortium: Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011, 7: e1002216-10.1371/journal.pgen.1002216.View ArticlePubMedPubMed CentralGoogle Scholar
  18. De Nitto D, Sarra M, Pallone F, Monteleone G: Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol. 2010, 16: 3638-3641. 10.3748/wjg.v16.i29.3638.View ArticlePubMedGoogle Scholar
  19. Leonard WJ, Spolski R: Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005, 5: 688-698. 10.1038/nri1688.View ArticlePubMedGoogle Scholar
  20. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/13/26/prepub

Copyright

© Zhang et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement